Intelectual Property

S.I.S has been granted a key patent in the US which is in various stages of approval worldwide US Patent - 7220725 Composition comprising an analgesic peptide and therapeutic use thereof Pending - As of March 2012, a new PTC patent (#PCT/IL2012/050105) was submitted (U.S. application - # 61/468,212) “Method for treating disorders of the skin” claiming the therapeutic use of the peptides as a treatment for viral induced clinical symptoms, such as HSV1 induced cold sores, HSV2 induced Genital Herpes and Psoriasis.